The impact of methicillin resistance on the outcome of poststernotomy mediastinitis due to Staphylococcus aureus

Clinical Infectious Diseases

Volumn 38, Issue 6, 2004, Pages 822-829

  Combes, Alain ^a   Trouillet, Jean Louis ^a   Joly Guillou, Marie Laure ^b   Chastre, Jean ^a   Gibert, Claude ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFAMANDOLE; COTRIMOXAZOLE; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; OFLOXACIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CATHETER; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INCUBATION TIME; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORALITY; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STERNOTOMY; ANTIBIOTIC RESISTANCE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

AGED; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MEDIASTINITIS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 1642304685     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/381890     Document Type: Article

References (49)

1. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21:1417-23.
2. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100:509-16.
3. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996; 23:255-9.
4. Law MR, Gill ON. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect 1988; 101:623-9.
5. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150:1545-9.
6. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Post-sternotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 2001; 32:877-83.
7. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229-35.
8. Talon D, Woronoff-Lemsi MC, Limat S, et al. The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 2002; 13:31-6.
9. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-7.
10. Ibelings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998; 164:411-8.
11. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36:592-8.
12. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
13. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158:182-9.
14. Tumbarello M, De Gaetano Donati K, Tacconelli E, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002; 50:375-82.
15. Soriano A, Martinez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30:368-73.
16. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160:1001-4.
17. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31:1170-4.
18. Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control 1985; 13:109-14.
19. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992; 13:587-93.
20. Mylotte JM, Aeschlimann JR, Rotella DL. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol 1996; 17:165-8.
21. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9:891-907.
22. Marty L, Flahault A, Suarez B, Caillon J, Hill C, Andremont A. Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteremic cancer patients. Intensive Care Med 1993; 19:285-9.
23. French GL, Cheng AF, Ling JM, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990; 15:117-25.
24. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphyhcoccus aureus bacteremia? Infect Control Hosp Epidemiol 2000; 21:645-8.
25. Farinas MC, Gald Peralta F, Bernal JM, Rabasa JM, Revuelta JM, Gonzalez-Macias J. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 1995; 20:272-9.
26. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990; 49:179-86.
27. Sarr MG, Gott VL, Townsend TR. Mediastinal infection after cardiac surgery. Ann Thorac Surg 1984; 38:415-23.
28. Combes A, Trouillet JL, Baudot J, Mokhtari M, Chastre J, Gibert C. Is it possible to cure mediastinitis in patients with major postcardiac surgery complications? Ann Thorac Surg 2001; 72:1592-7.
29. Berg HF, Brands WG, van Geldorp TR, Kluytmans-VandenBergh FQ, Kluytmans JA. Comparison between closed drainage techniques for the treatment of postoperative mediastinitis. Ann Thorac Surg 2000; 70:924-9.
30. Calvat S, Trouillet JL, Nataf P, Vuagnat A, Chastre J, Gibert C. Closed drainage using Redon catheters for local treatment of poststernotomy mediastinitis. Ann Thorac Surg 1996; 61:195-201.
31. Durandy Y, Batisse A, Bourel P, Dibie A, Lemoine G, Lecompte Y. Mediastinal infection after cardiac operation: a simple closed technique. J Thorac Cardiovasc Surg 1989; 97:282-5.
32. Kirsch M, Mekontso-Dessap A, Houel R, Giroud E, Hillion ML, Loisance DY. Closed drainage using Redon catheters for poststernotomy mediastinitis: results and risk factors for adverse outcome. Ann Thorac Surg 2001; 71:1580-6.
33. Members of the SFM Antibiogram Committee. Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int J Antimicrob Agents 2003; 21:364-91.
34. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med 1962; 110:847-64.
35. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
36. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993; 19:137-44.
37. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-7.
38. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-74.
39. Rochon-Edouard S, Pestel-Caron M, Lemeland JF, Caron F. In vitro synergistic effects of double and triple combinations of β-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2000; 44:3055-60.
40. Lodise TP, McKinnon PS, Donald P, Levine DP, Rybak MJ. Predictor of mortality and impact of initial therapy on outcomes in intravenous drug users with Staphylococcus aureus infective endocarditis [L-765]. In: Program and abstracts of the 42nd International Conference on Antimicrobial Agents and Chemotherapy (San Diego, CA). Washington, DC: ASM Press, 2002:352.
41. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002; 123:326-32.
42. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990; 34:1227-31.
43. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115:674-80.
44. Schmitz FJ, MacKenzie CR, Geisel R, et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur J Epidemiol 1997; 13:699-708.
45. Hewitt JH, Sanderson PJ. The effect of methicillin on skin lesions in guinea-pigs caused by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Med Microbiol 1974; 7:223-35.
46. Cutler RR. Relationship between antibiotic resistance, the production of virulence factors and virulence for experimental animals in Staphylococcus aureus. J Med Microbiol 1979; 12:55-62.
47. Vaudaux P, Waldvogel FA. Methicillin-resistant strains of Staphylococcus aureus: relation between expression of resistance and phagocytosis by polymorphonuclear leukocytes. J Infect Dis 1979; 139:547-52.
48. Ward TT. Comparison of in vitro adherence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells. J Infect Dis 1992; 166:400-4.
49. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61:1030-6.